ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

436
Analysis
Health Care • South Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
bearish•Quantitative Analysis
•21 Aug 2019 05:40

Korea Short Interest - Numb3rs & Ch@rts

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 16 August. Current...

Logo
587 Views
Share
bearish•Quantitative Analysis
•13 Aug 2019 10:30

KOSPI Short Interest and a Trading Strategy

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag.Current short notional on the KOSPI market is KRW...

Logo
645 Views
Share
bearish•Samsung Electronics
•24 Jun 2019 15:28
Smartkarma Originals

Samsung Electronics. A Bearish Investment Thesis.

EXECUTIVE SUMMARY We have a negative view of Samsung Electronics over the next one to two years. We believe investors will have an opportunity to...

Logo
1.2k Views
Share
bullish•Wuxi Biologics
•18 Jun 2019 23:07

WuXi Biologics Placement: Attractive in the Context of Market, Financials and Valuation

Wuxi Biologics (Cayman) Inc (2269 HK) is a global one-stop biologics services provider and often referred to as CRO (contract research...

Logo
680 Views
Share
bearish•Celltrion Healthcare
•24 Feb 2019 12:05

Celltrion Healthcare: Well, We Were Warned

Celltrion Healthcare (091990 KS) reported preliminary 2018 results that were dramatically short of expectations as the company cut shipments to...

Share
x